136
Participants
Start Date
July 3, 2018
Primary Completion Date
June 18, 2020
Study Completion Date
January 3, 2023
Pamiparib
60 mg orally twice daily
Placebo
60 mg orally twice daily
Chi Mei Medical Center, Tainan City
Orszagos Onkologiai Intezet, Budapest
Gosford Hospital, Gosford
University Hospitals Leuven, Leuven
Monash Health, Clayton
Ballarat Oncology and Haematology Services, Wendouree
St John of God Health Care, Subiaco
Az Sint Jan Brugge, Bruges
Fakultni Nemocnice Bulovka, Prague
Hopital Prive Des Cotes Darmor Service Oncologie, Plérin
Icm Val Daurelle Oncologie Medicale, Montpellier
Chu Besancon Hopital Jean Minjoz, Doubs
Hospital Universitario Ramon Y Cajal, Madrid
Hospital Universitario Hm Madrid Sanchinarro, Madrid
Novant Health Hematology Charlotte, Charlotte
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda
Chru de Brest Hospital Morvan, Brest
Clinica Universidad de Navarra Pamplona, Pamplona
Iuc Toulouse Oncopole, Toulouse
Miami Cancer Institute, Miami
Scri Florida Cancer Specialist East, West Palm Beach
Centre Eugene Marquis, Rennes
Norton Cancer Institute, Louisville
Ico Site Rene Gauducheau, SaintHerblain
Hospital Clinico Universitario de Valencia, Valencia
Goshen Center For Cancer Care, Goshen
Cancer Center of Kansas, Wichita
Hopital Prive Jean Mermoz, Lyon
Institut Gustave Roussy, Villejuif
Oregon Health and Science University, Portland
Beijing Cancer Hospital, Beijing
Liaoning Cancer Hospital and Institute, Shenyang
Arkhangelsk Regional Clinical Oncological Dispensary, Arkhangelsk
Pavlov First Saint Petersburg State Medical University, SaintPetersburg
Affiliated Zhongshan Hospital of Fudan University, Shanghai
Nanjing Drum Tower Hospital,the Affiliated Hospital of Nanjing University Medical School, Nanjing
Anhui Provincial Hospital, Hefei
Shandong Cancer Hospital, Jinan
The Affiliated Hospital of Qingdao University Branch South, Qingdao
Regional Buz Kurskiy Regional Clinical Oncologic Dispensary, Kursk
Tan Tock Seng Hospital Oncology, Singapore
State Budgetary Healthcare Institution Volgograd Regional Clinical Oncology Dispensary, Volgograd
Sun Yat Sen University Cancer Center, Guangzhou
Nanfang Hospital of Southern Medical University, Guangzhou
Cancer Hospital of Shantou University Medical College, Shantou
Bih of Omsk Region Clinical Oncology Dispensary, Omsk
Acad Fridon Todua Medical Center Ltd Research Institute of Clinical Medicine Ltd, Tbilisi
Queen Mary Hospital, Hong Kong
Pecsi Tudomanyegyetem Klinikai Kozpont, Pécs
Nho Kyushu Cancer Center, Fukuoka
Kindai University Nara Hospital, Ikoma
Oita University Hospital, Yufushi
Kindai University Hospital, Sayama
Osaka University Hospital, Suitashi
Saitama Medical University International Medical Center, Hidakashi
Showa University Koto Toyosu Hospital Oncology, Koto
Szpitale Pomorskie Spolka Z Ograniczona Odpowiedzialnoscia, Gdynia
Centrum Onkologii Ziemi Lubelskiej, Lublin
Narodowy Instytut Onkologii Im Marii Skodowskiej Curie Pastwowy Instytut Badawczy, Warsaw
Mazowiecki Szpital Onkologiczny, Wieliszew
Hospital de La Santa Creu I Sant Pau, Barcelona
Hospital Universitario Vall Dhebron, Barcelona
Institut Catala Doncologia, Barcelona
Sarah Cannon Research Institute Uk, London
Clatterbridge Cancer Centre, Metropolitan Borough of Wirral
Lead Sponsor
BeiGene
INDUSTRY